US Stock MarketDetailed Quotes
NEUP Neuphoria Therapeutics
- 4.060
- -2.570-38.76%
Trading Dec 26 10:19 ET
6.61MMarket Cap-0.26P/E (TTM)
4.993High3.900Low297.52KVolume4.900Open6.630Pre Close1.28MTurnover21.34%Turnover RatioLossP/E (Static)1.63MShares18.00052wk High0.39P/B5.66MFloat Cap2.12452wk Low--Dividend TTM1.39MShs Float264.000Historical High--Div YieldTTM16.48%Amplitude2.112Historical Low4.312Avg Price1Lot Size
Neuphoria Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 181.36K | 0 | 32.06K |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --181.36K | --0 | --32.06K |
| Cost of revenue | ||||||||
| Gross profit | ||||||||
| Operating expense | -34.75%3.57M | -17.45%17.8M | 3.89M | 5.47M | 45.07%21.56M | 65.92%14.86M | 43.87%8.96M | 6.23M |
| Selling and administrative expenses | -29.95%1.67M | -4.90%8.47M | --1.82M | --2.38M | 69.09%8.91M | 24.25%5.27M | 27.25%4.24M | --3.33M |
| -General and administrative expense | -29.95%1.67M | -4.90%8.47M | --1.82M | --2.38M | 69.09%8.91M | 24.25%5.27M | 27.25%4.24M | --3.33M |
| Research and development costs | -38.45%1.9M | -27.95%9.42M | --2.18M | --3.09M | 18.77%13.07M | 154.21%11.01M | 8.12%4.33M | --4M |
| Other operating expenses | ---- | 77.48%-95.22K | ---- | ---- | 70.09%-422.74K | -465.48%-1.41M | 134.79%386.74K | ---1.11M |
| Operating profit | 34.75%-3.57M | 17.45%-17.8M | -3.89M | -5.47M | -46.86%-21.56M | -63.89%-14.68M | -44.61%-8.96M | -6.19M |
| Net non-operating interest income expense | -58.24%36.1K | -31.89%220.1K | 49.01K | 86.44K | 1,469.75%323.16K | 97.82%-23.59K | 12.06%-1.08M | -1.23M |
| Non-operating interest income | -58.24%36.1K | -31.89%220.1K | --60.96K | --86.44K | 4,660.04%323.16K | 56.98%6.79K | -89.22%4.32K | --40.11K |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | -97.90%18.49K | -28.44%882.32K | --1.23M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | -94.13%11.9K | 465.23%202.52K | --35.83K |
| Other net income (expense) | 2,156.10%2.59M | 803.93%2M | -1.19M | -126.19K | 28.30%-283.78K | -111.77%-395.78K | 2.47%3.36M | 3.28M |
| Gain on sale of security | 2,156.10%2.59M | 803.93%2M | ---255.09K | ---126.19K | -215.82%-283.78K | -69.85%245.01K | 290.42%812.52K | ---426.71K |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | -126.91%-645.38K | -32.85%2.4M | --3.57M |
| -Less：Restructuring and merger&acquisition | ---- | ---- | ---- | ---- | ---- | 126.69%644.13K | 27.18%-2.41M | ---3.31M |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---136.8K |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---- | ---- | 92.04%-1.26K | -113.21%-15.79K | --119.51K |
| Other non- operating income (expenses) | ---- | ---- | ---- | ---- | ---- | -96.99%4.59K | 10.84%152.53K | --137.62K |
| Income before tax | 82.99%-936.97K | 27.61%-15.58M | -5.04M | -5.51M | -42.52%-21.52M | -126.22%-15.1M | -61.20%-6.68M | -4.14M |
| Income tax | -279.92%-132.19K | 37.26%-87.32K | -37.85K | -34.79K | -5.48%-139.17K | 6.30%-131.95K | 1.29%-140.82K | -142.65K |
| Net income | 85.29%-804.79K | 27.54%-15.49M | -5M | -5.47M | -42.84%-21.38M | -129.07%-14.97M | -33.60%-6.53M | -4.89M |
| Net income continuous Operations | 85.29%-804.79K | 27.54%-15.49M | ---5M | ---5.47M | -42.84%-21.38M | -129.07%-14.97M | -63.43%-6.53M | ---4M |
| Net income discontinuous operations | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---892.78K |
| Minority interest income | ||||||||
| Net income attributable to the parent company | 85.29%-804.79K | 27.54%-15.49M | -5M | -5.47M | -42.84%-21.38M | -129.07%-14.97M | -33.60%-6.53M | -4.89M |
| Preferred stock dividends | ||||||||
| Other preferred stock dividends | ||||||||
| Net income attributable to common stockholders | 85.29%-804.79K | 27.54%-15.49M | -5M | -5.47M | -42.84%-21.38M | -129.07%-14.97M | -33.60%-6.53M | -4.89M |
| Basic earnings per share | 92.17%-0.0034 | 50.00%-0.12 | -0.0026 | -0.0439 | -45.37%-0.24 | -83.12%-0.1651 | -9.35%-0.0902 | -0.0825 |
| Diluted earnings per share | 92.17%-0.0034 | 50.00%-0.12 | -0.0026 | -0.0439 | -45.37%-0.24 | -83.12%-0.1651 | -9.35%-0.0902 | -0.0825 |
| Dividend per share | ||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion | Unqualified Opinion | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
